cro.directory
← Compare landing

BioLegacy Research vs Biotest Facility

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/biolegacy/bioxpedia

CategoryBioLegacy ResearchBiotest Facility
Listed sitecrocro
SummarySan Diego-based preclinical CRO specializing in GLP toxicology, in vivo pharmacology, custom animal models, and medical device testing across rodent to non-human primate species.Danish CRO offering in vivo models, proteomics, transcriptomics, biomarker discovery, and bioinformatics to support biotech and pharma research from concept to validated data.
Services
  • GLP Toxicology
  • Safety Pharmacology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Specialized & Large-Animal Models
  • Device & Combination Product Services
  • Pathology & Histology Services
  • Bioanalysis
  • Preclinical In Vivo Studies
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • GLP Toxicology
  • Proteomics Services
  • Genomics & Sequencing Services
  • Biomarker Assays
  • LC-MS Bioanalysis (Small Molecule)
  • Bioanalysis
  • Biostatistics & Statistical Programming
  • Translational Research
  • Bioinformatics & Data Science
  • Data Management & eClinical
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • In Vitro ADME / DMPK
ModalitiesData not yet provided.
  • Small Molecule
  • Peptide
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
Locations
  • Headquarters, San Diego, California, United States
  • Headquarters, Trige, Aarhus, Denmark
  • Headquarters, Denmark
  • Headquarters, Denmark, Denmark
CertificationsData not yet provided.
  • Danish CVR · Identifier: 37974382
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.